|
SESTD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.444100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.474800E-01 |
| Normal-vs-Stage2 |
1.448420E-01 |
| Normal-vs-Stage3 |
4.08839999632704E-08 |
| Normal-vs-Stage4 |
2.88480350718601E-11 |
| Stage1-vs-Stage2 |
2.463000E-01 |
| Stage1-vs-Stage3 |
7.92930000548253E-08 |
| Stage1-vs-Stage4 |
5.10069764203536E-12 |
| Stage2-vs-Stage3 |
2.496200E-02 |
| Stage2-vs-Stage4 |
1.840090E-03 |
| Stage3-vs-Stage4 |
1.611840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.582900E-04 |
| Normal-vs-AfricanAmerican |
4.882200E-02 |
| Normal-vs-Asian |
3.048200E-01 |
| Caucasian-vs-AfricanAmerican |
6.911800E-01 |
| Caucasian-vs-Asian |
7.322300E-02 |
| AfricanAmerican-vs-Asian |
1.122570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.44340000002497E-06 |
| Normal-vs-Female |
2.266800E-01 |
| Male-vs-Female |
3.018900E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.054050E-02 |
| Normal-vs-Age(41-60Yrs) |
4.643500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.72487999999804E-05 |
| Normal-vs-Age(81-100Yrs) |
9.801600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.120000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.958000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.788400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.222490E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.431600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.233000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.437230E-01 |
| Normal-vs-Grade 2 |
7.327800E-01 |
| Normal-vs-Grade 3 |
6.99979999962963E-07 |
| Normal-vs-Grade 4 |
1.63857816204427E-12 |
| Grade 1-vs-Grade 2 |
2.327600E-01 |
| Grade 1-vs-Grade 3 |
6.049000E-04 |
| Grade 1-vs-Grade 4 |
2.160400E-04 |
| Grade 2-vs-Grade 3 |
2.70399999946491E-07 |
| Grade 2-vs-Grade 4 |
1.62481139653892E-12 |
| Grade 3-vs-Grade 4 |
2.02889999999512E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.307400E-01 |
| Normal-vs-ccB subtype |
2.83930001732102E-09 |
| ccA subtype-vs-ccB subtype |
2.95319324550292E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.661800E-03 |
| Normal-vs-N1 |
2.48349999998343E-06 |
| N0-vs-N1 |
1.314060E-02 |
|
|
